ZEMEL ELLIOT enters CANNAPHARMARX, INC. with 23.37M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 4/10/2025ACC: 0001213900-25-030782
23.37M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
3 instruments
1
Security positions
23.37M indirect
Non-Derivative Holdings1
Common shares
IndirectShares owned23.37M
Total
23.37M indirect23.37M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common shares | 23.37M | Indirect |
| Total | 23.37M | 23.37M indirect |
Derivative Holdings3
Convertible notes
IndirectUnderlying security
Common Stock
Underlying shares
N/A
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series C Preferred
IndirectUnderlying security
Common Stock
Underlying shares
N/A
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Warrants
IndirectUnderlying security
Common Stock
Underlying shares
N/A
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
0.00
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Convertible notes Indirect | Common Stock | — | — | N/A | N/A | |
| Series C Preferred Indirect | Common Stock | — | — | N/A | N/A | |
| Warrants Indirect | Common Stock | — | — | N/A | N/A | |
| Total | 0.00 | 0.00 | ||||